Ambulatory Infusion Centers Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 46.09 Billion |
| Market Size (2029) | USD 76.23 Billion |
| CAGR (2024 - 2029) | 10.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Ambulatory Infusion Centers Market Analysis
The Ambulatory Infusion Centers Market size is estimated at USD 46.09 billion in 2024, and is expected to reach USD 76.23 billion by 2029, growing at a CAGR of 10.60% during the forecast period (2024-2029).
Ambulatory infusion therapy is a facility that provides medical treatment outside the hospital. With the increase in demand for infusion therapy at alternate sites such as ambulatory infusion centers, there has been an upward trend in recent years for these centers. Also, the growing government initiatives to enhance healthcare facilities influence market growth. For instance, in March 2023, the US Department of Veterans Affairs (VA) launched an innovative program called "Close to Me Novel Infusion Care Delivery service," which aimed at reducing travel time for treatment to healthcare settings for Veterans. Through this program, twelve VA facilities across the country were selected for infusion treatment. This program covers eight CBOC care models, three home care models, and one mobile infusion unit site for infusion treatment at the initial stage.
Furthermore, the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, etc., fuels the growth of the ambulatory infusion centers market. This growing prevalence of chronic diseases requires more infusion treatment at home or in ambulatory infusion centers, which is one of the major factors responsible for the growth of the ambulatory infusion centers market. For instance, according to the British Heart Foundation, in 2023, around 620 million people were living with heart and circulatory diseases globally, and around 60 million people across the world develop a heart or circulatory disease every year.
In addition, rising demand for cost-effective and patient-centric healthcare solutions has also been fueling the growth of the ambulatory infusion centers market in recent years. There is a growing emphasis on patient-centered care, prioritizing treatments that can be delivered in the least disruptive manner possible in a cost-effective way, compelling healthcare providers to adopt this model. Hence, growing emphasis and demand for innovative solutions are fueling the growth of the ambulatory infusion centers market. For instance, Driscoll Children's Hospital in Texas, United States, adopted an innovative approach in 2022 for patient appointments on the same day for two or more specialties on the same day. Through this initiative, the project team set higher patient visit targets for each coming year, with an end goal to maintain or improve a rate of 8% from August 31, 2023, through August 31, 2025.
However, limited reimbursement coverage at specific sites, less digital transformation in developing countries, and more complex patient conditions restrain the market growth.
Ambulatory Infusion Centers Market Trends
The Oncology Segment is Expected to Witness Significant Growth Over the Forecast Period
The oncology segment by application covers the application of drug administration through infusion or intravenous routes at ambulatory infusion centers. There are a lot of drugs for chemotherapies that are given as an infusion or injection at these facilities. The growing demand for ambulatory infusion therapy for cancer, coupled with growing cancer cases in recent years, is the major driving factor responsible for the growth of the oncology segment. For instance, as per the World Health Organization (WHO), there were an estimated 20 million new cancer cases in 2022 across the globe.
Moreover, the launch of targeted infusion therapy for cancer in recent years is also fueling the growth of the oncology segment in the global ambulatory infusion centers market. For instance, in August 2022, the US FDA approved the first targeted therapy trastuzumab deruxtecan (T-DXd) of AstraZeneca, for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed.
Additionally, companies have focused more on technological advancements in infusion therapy for cancer treatment, which is also one of the major driving factors responsible for the growth of the oncology segment. These technological advancements, such as smart pump can be observed in intelligent pump integration, remote monitoring, etc., are some of the major driving factors to propel the segment's growth in recent years. In March 2022, MicroPort Lifesciences received marketing approval from China's National Medical Products Administration (NMPA) for its independently developed new AutoEx Chemotherapy Infusion Pump (AutoEx). AutoEx is a portable infusion pump with a dual CPU control system and dual power supply that can provide high-precision drug delivery control and improve patient comfort safely and reliably.
Hence, the above-mentioned factors, such as the rising prevalence of cancer across the globe, recent product approvals for target infusion therapy, and technological advancements in infusion therapy, will drive the growth of the oncology segment in the upcoming years.
North America is Expected to Dominate the Ambulatory Infusion Centers Market
North America is expected to dominate the market due to factors such as the increasing prevalence of cancer and cardiovascular diseases, increasing government support programs for ambulatory infusion centers, and growing demand for ambulatory infusion suites in the region. For instance, as per the American Cancer Society, Inc., an estimated 2.1 million new cancer cases are expected to be reported in 2024 in the United States. Also, as per the Canadian Cancer Society, there were 239,100 new cancer cases and 86,700 cancer deaths were reported in Canada in 2023.
Moreover, rising product approval and the launch of infusion products for cancer and other chronic diseases are also fueling the growth of the North America Ambulatory Infusion Centers Market. In November 2023, the US FDA approved AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) in the US for the treatment of adult patients with hormone receptor (HR)-positive HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN).
Therefore, owing to the factors mentioned above, the growth of the studied market is anticipated in the North American region.
Ambulatory Infusion Centers Industry Overview
The ambulatory infusion centers market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market share and are well known, including Coram LLC, Option Carc e Health Inc., UnitedHealth Group, PharmaScript, Cleveland Clinic, UK Healthcare (University of Kentucky), Stoughton Health, CHI Mercy Medical Center, HATTIESBURG CLINIC, PharMerica Corporation, IVXpress, Inc., and Arnot Health, among others.
Ambulatory Infusion Centers Market Leaders
-
Coram LLC
-
Option Care Health Inc.
-
UNITEDHEALTH GROUP
-
PharmaScript
-
Cleveland Clinic
*Disclaimer: Major Players sorted in no particular order
Ambulatory Infusion Centers Market News
• In February 2024, New Harbor Capital completed the majority of investments in Ambulatory Infusion Care North Inc. and JLS Infusion Nurse Staffing Services LLC to form Access Infusion Care. The combined Company will serve as the platform for New Harbor's infusion therapy strategy, which aims to acquire high-quality infusion providers in underserved geographies with diversified therapy offerings and delivery settings and outsized growth potential.
• In January 2024, Elevance 1Health agreed to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. Elevance 1Health will enhance its position in the ambulatory infusion services market through this acquisition.
• In August 2023, Uptiv Health launched a new hybrid infusion care company focusing on reshaping the patient experience. The startup opened its first location in Michigan, US.
Ambulatory Infusion Centers Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Government Initiatives to Enhance Healthcare Facilities
- 4.2.2 Increasing Prevalence of Chronic Diseases
- 4.2.3 Rising Demand for Cost-Effective and Patient-Centric Healthcare Solutions
-
4.3 Market Restraints
- 4.3.1 Limited Reimbursement Coverage at Certain Sites
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Therapy Type
- 5.1.1 Antibiotic, anti-fungal, anti-viral medication
- 5.1.2 Blood Product Infusion
- 5.1.3 Iron Therapy
- 5.1.4 Steroid Infusion
- 5.1.5 Immunoglobulin Therapy
- 5.1.6 Clotting Factor Replacement Therapy
- 5.1.7 Plasmapheresis
- 5.1.8 Other Therapy Types (Therapeutic Phlebotomy, etc.)
-
5.2 By Application
- 5.2.1 Oncology
- 5.2.2 Neurology
- 5.2.3 Gastro-intestinal Disorders
- 5.2.4 Nutrition Support
- 5.2.5 Other Applications (Rheumatology, Immunology, etc.)
-
5.3 By Site of Care
- 5.3.1 Hospitals
- 5.3.2 Clinics
- 5.3.3 Freestanding Infusion Centers
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Rest of the World
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Coram LLC
- 6.1.2 Option Care Health Inc.
- 6.1.3 UNITEDHEALTH GROUP
- 6.1.4 PharmaScript
- 6.1.5 Cleveland Clinic
- 6.1.6 UK Healthcare(University of Kentucky)
- 6.1.7 Stoughton Health
- 6.1.8 CHI Mercy Medical Center
- 6.1.9 HATTIESBURG CLINIC
- 6.1.10 PharMerica Corporation
- 6.1.11 IVXpress, Inc.
- 6.1.12 Arnot Health
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAmbulatory Infusion Centers Industry Segmentation
An ambulatory infusion center is a facility center that provides medical treatment outside of the hospital. With the emergence of infusion therapy, these infusion therapies are commonly available in many centers. These ambulatory infusion facility centers are specially designed to provide comfort and ease of relaxation. They provide a special space for the patient that makes their infusion session more effective. People who don’t respond to medicine well can get infusion therapy to recover quickly. Yet, they still avoid the total costs of being admitted to a hospital or nursing home.
The ambulatory infusion centers market is segmented into therapy type, application, site of care, and geography. The market is segmented by therapy type into Antibiotic, anti-fungal, anti-viral medication, blood product infusion, iron therapy, steroid infusion, immunoglobulin therapy, clotting factor replacement therapy, plasmapheresis, and Others. By application, the market is divided into oncology, neurology, gastrointestinal disorders, nutrition support, and others. By site of care, the market is segmented into hospitals, clinics, and Freestanding Infusion Centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report also offers the market size and forecasts for 15 countries across the region. For each segment, the market sizing and forecasts were made on the basis of value (USD).
| By Therapy Type | Antibiotic, anti-fungal, anti-viral medication | |
| Blood Product Infusion | ||
| Iron Therapy | ||
| Steroid Infusion | ||
| Immunoglobulin Therapy | ||
| Clotting Factor Replacement Therapy | ||
| Plasmapheresis | ||
| Other Therapy Types (Therapeutic Phlebotomy, etc.) | ||
| By Application | Oncology | |
| Neurology | ||
| Gastro-intestinal Disorders | ||
| Nutrition Support | ||
| Other Applications (Rheumatology, Immunology, etc.) | ||
| By Site of Care | Hospitals | |
| Clinics | ||
| Freestanding Infusion Centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Rest of the World |
Ambulatory Infusion Centers Market Research FAQs
How big is the Ambulatory Infusion Centers Market?
The Ambulatory Infusion Centers Market size is expected to reach USD 46.09 billion in 2024 and grow at a CAGR of 10.60% to reach USD 76.23 billion by 2029.
What is the current Ambulatory Infusion Centers Market size?
In 2024, the Ambulatory Infusion Centers Market size is expected to reach USD 46.09 billion.
Who are the key players in Ambulatory Infusion Centers Market?
Coram LLC, Option Care Health Inc., UNITEDHEALTH GROUP, PharmaScript and Cleveland Clinic are the major companies operating in the Ambulatory Infusion Centers Market.
Which is the fastest growing region in Ambulatory Infusion Centers Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Ambulatory Infusion Centers Market?
In 2024, the North America accounts for the largest market share in Ambulatory Infusion Centers Market.
What years does this Ambulatory Infusion Centers Market cover, and what was the market size in 2023?
In 2023, the Ambulatory Infusion Centers Market size was estimated at USD 41.20 billion. The report covers the Ambulatory Infusion Centers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Ambulatory Infusion Centers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Ambulatory Infusion Centers Industry Report
Statistics for the 2024 Ambulatory Infusion Centers market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Ambulatory Infusion Centers analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
